Human Milk Oligosaccharides
Human Milk Oligosaccharides Market by Product (2’-Fucosyllactose(2’FL), 3’-Fucosyllactose (3’FL), 3’-Sialyllactose (3’SL)), Type (Acidic, Neutral), Application - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the human milk oligosaccharides market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[189 Pages Report] The Human Milk Oligosaccharides Market size was estimated at USD 297.90 million in 2023 and expected to reach USD 323.44 million in 2024, at a CAGR 9.72% to reach USD 570.55 million by 2030.

Human milk oligosaccharides (HMOs) are a mixed group of complex carbohydrates naturally present in human breast milk. They represent human milk's third enormous solid component after lactose and fat. As non-digestible food ingredients, HMOs serve multiple functions that contribute to the advantageous effects of human milk on infant health and development. HMOs play a critical role in developing an infant's gut microbiota, acting as prebiotics by selectively encouraging the development of beneficial bacteria, including Bifidobacteria and Lactobacillus. This helps establish a healthy intestinal environment that supports nutrient absorption and protects against pathogenic bacteria. Additionally, their utilization extends into functional foods and dietary supplements owing to their prebiotic and anti-pathogenic properties. HMOs are also studied for therapeutic potentials in gastroenterology, immunology, and oncology. The market is driven by the scientific consensus on the advantages of breastfeeding and the rising awareness of the benefits of HMOs. Technological advancements in the synthesis and extraction of HMOs contribute to market expansion. A growing infant formula industry, rising health concerns, and increasing purchasing power contributed significantly to the HMO market's growth. However, the growth of HMOs is hampered by high research and development costs associated with HMO production, regulatory challenges, the requirement for extensive safety evaluations before approvals, and the complexity of synthesizing HMOs that are identical to the ones found in human milk. On the other hand, the latest potential opportunities in the HMO market include the development of new and more cost-effective extraction and synthesis methods for a broader range of HMO compounds. Another area of opportunity lies in expanding the applications beyond dietary supplements and infant nutrition, particularly in gut health, immunity boosters, and therapeutic agents. Collaboration with healthcare institutions for clinical trials and academic institutions for research can create opportunities for market players.

Regional Insights

The United States holds a significant share of the global HMOs market, driven by robust R&D initiatives and consumer awareness regarding infant nutrition. The region has witnessed growing demand for HMO-enhanced infant formula, attributed to the increasing need for nutritionally rich alternatives to breast milk. In Canada, consumer interest in advanced nutritional compositions for infants, including HMO-supplemented formulas, is growing. However, the market is just budding, and consumer purchasing behavior tends to lean toward trusted brands and scientifically backed products. The market for HMOs in South America is in a developing stage. Countries such as Brazil and Argentina are increasingly demanding advanced infant nutrition products. The European Union presents a mature market for HMOs, with a strong focus on infant nutrition and well-being. Countries such as Denmark and Germany are leading in terms of HMO research and production. EU regulations are stringent on product safety and quality, requiring companies to undergo rigorous evaluations. This has led to a customer base that is well-informed and discerning. While the market for HMOs is less pronounced in the Middle East and Africa, there is a noticeable increase in demand tied to rising incomes and an emerging middle class. Interest in advanced nutritional formulas for infants is growing, although the awareness and understanding of HMOs benefits are still developing. The APAC region is witnessing a rapid increase in demand for HMOs, particularly in countries such as India, China, and Japan. China has quickly become a primary market for HMOs in Asia, with national policies endorsing breastfeeding and higher-quality infant formula. Japan is known for its high standards in food safety and quality, which extends to the HMO market. Japanese consumers are health-conscious and show readiness to adopt scientifically-supported products, contributing to a steady demand for HMO-supplemented formulas. India is seen as an emerging market with vast potential for HMOs due to its large population and increasing focus on nutritional security. The awareness of the importance of early childhood nutrition is on the rise, and companies aim to capture this market by scaling up investment and promoting informed consumer behavior.

Human Milk Oligosaccharides Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Human Milk Oligosaccharides Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Increase HMO Application in Infant Formula and Functional Food owing to the Nutritional Value
    • Rising Awareness Regarding the Concerns Related to Child Malnourishment and Mortality all Over the Globe
    • Increasing Demand for HMOs Supplements in Adults
  • Market Restraints
    • High Cost associated with the R&D and Large Production
  • Market Opportunities
    • Advancement in the Product Line of HMOs
    • Rising Demand for Nutritional Supplements from China and India
  • Market Challenges
    • Regulatory Framework Specific to Countries and Regions
Market Segmentation Analysis
  • Product: Increasing preference for 2’-Fucosyllactose(2’FL) due to its abundance in human milk and proven health benefits

    2'-Fucosyllactose (2’FL) is the most abundant oligosaccharide present in human milk, particularly in the milk of mothers who are secretors of the H antigen. It is reputed for its prebiotic effects, such as supporting a healthy gut microbiota and stimulating the immune system. Consequently, the need for 2’FL is paramount in infant formula to emulate some of these benefits found in breast milk. 3’-Fucosyllactose (3’FL) is increasingly recognized for its role in developing the immune system and modulating the gut environment. It is considered a significant HMO for infant nutrition due to its potential role in protecting against pathogens. Demand for 3’FL is rising in the development of next-generation infant formula and child nutritional products. 3’-Sialyllactose (3’SL) contains sialic acid, crucial for brain development and cognitive function. There is a preference for 3’SL in products promoting infant neurological development. Another sialic acid-containing oligosaccharide, 6’-Sialyllactose (6’SL), is vital for brain development and may have roles in modulating cell adhesion and signaling. Its inclusion in infant nutrition products is highly valued for these reasons. Lacto-N-neotetraose (LNnT) has garnered interest due to its structural similarity with critical cell surface glycan structures, potentially playing a part in preventing pathogen adhesion in the gut. Its application extends to both infant formulas and dietary supplements. Lacto-N-tetraose (LNT) is crucial for infant gut maturation and the development of the microflora. While its market penetration is less than that of other HMOs, interest in LNT is increasing, particularly for its role in supporting the immune system and preventing gastrointestinal infections.

  • Application: Growing application of HMOs for replicating the complex health-sustaining properties of breast milk for infants

    HMOs are increasingly incorporated into functional food and dietary supplements owing to their multiple health benefits. HMOs are known to support digestive health, enhance immune function, and potentially lower the danger of certain infections. They are prebiotic substances that foster a beneficial environment for gut microbiota, which is crucial for overall wellness. The need for HMOs in functional foods and supplements is particularly strong among consumers looking to improve gut health and boost immunity. The most prominent application of HMOs is in infant formula, given their role in mimicking the composition of human breast milk. These complex carbohydrates are the third-most abundant solid component in human milk and are crucial for the development of an infant's gut flora and immune system. In the segment of infant formula, HMOs address the needs of infants who may not have access to breast milk or require supplemental feeding. They are designed to support infants' brain development, digestive health, and immunity. In the laboratory research context, HMOs are valuable for their contribution to the scientific understanding of human milk, gastroenterology, neonatology, and immunology. Research applications include studies on prebiotic and probiotic effects, investigation into preventing necrotizing enterocolitis, and understanding the role of oligosaccharides in brain development and cognition. This need-based preference is driven primarily by academic, governmental, and industrial research institutions seeking to expand the frontier of knowledge on HMOs. Each HMO application segment addresses a different need and operates within unique market dynamics. In functional food and supplements, the focus is on preventive health care and supplementing diets with additional nutritional benefits. In infant formulas, the emphasis is on replicating breast milk's complex health-sustaining properties for infants who cannot breastfeed. On the other hand, laboratory research is more about pushing the boundaries of scientific knowledge with less immediate commercial application.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Human Milk Oligosaccharides Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Human Milk Oligosaccharides Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Human Milk Oligosaccharides Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Human Milk Oligosaccharides Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Human Milk Oligosaccharides Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Human Milk Oligosaccharides Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Human Milk Oligosaccharides Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Human Milk Oligosaccharides Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Human Milk Oligosaccharides Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Human Milk Oligosaccharides Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Human Milk Oligosaccharides Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Human Milk Oligosaccharides Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Nestlé launches its first product with HMOs in China, reinforcing its global leadership in nutrition science

    Nestlé S.A. has entered the early life nutrition market in mainland China, releasing its Wyeth illuma line of growing-up milk fortified with Human Milk Oligosaccharides (HMOs) following the National Health Commission's authorization. This product includes vital HMOs like 2'Fucosyllactose (2'FL) and Lacto-N-(neo)tetraose (LNnT), integral to boosting gut health, immunity, and cognitive development in young children. [Published On: 2023-11-23]

  • Firmenich Completes Merger Of Equals With Dsm

    Koninklijke DSM N.V. and Firmenich International SA have concluded their merger, creating DSM-Firmenich AG, a prominent player in nutrition, health, and beauty innovation. The completion follows the fulfillment of all standard regulatory conditions, including the execution of a share exchange offer and the integration of Firmenich shares into the merged entity. [Published On: 2023-05-09]

  • Novozymes Agrees to Buy Chr. Hansen in USD 12.3 Billion Deal

    Novozymes A/S has agreed to acquire Chr. Hansen Holding A/S for approximately USD 12.3 billion. The proposed stock-for-stock transaction is likely to enhance Novozymes' portfolio with Chr. Hansen's expertise in natural food ingredients and probiotics. [Published On: 2022-12-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Human Milk Oligosaccharides Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Human Milk Oligosaccharides Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Protein Technologies Corp., Agilent Technologies, Inc., BASF SE, Biosynth AG, Chr. Hansen Holding A/S, Conagen, Inc., Dextra Laboratories Ltd, DuPont de Nemours, Inc., Elicityl SA, Glycosyn LLC, Gnubiotics Sciences SA, Inbiose NV, Kirin Holdings Company, Limited, Koninklijke DSM N.V., Laïta Nutrition, Lonza Group AG, Nestlé S.A., Roquette Frères, Royal FrieslandCampina N.V., Tate & Lyle PLC, TurtleTree, and ZuChem, Inc..

Human Milk Oligosaccharides Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Human Milk Oligosaccharides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • 2’-Fucosyllactose(2’FL)
    • 3’-Fucosyllactose (3’FL)
    • 3’-Sialyllactose (3’SL)
    • 6’-Sialyllactose (6’SL)
    • Lacto-n-neotetraose (LNnT)
    • Lacto-n-tetraose (LNT)
  • Type
    • Acidic
    • Neutral
  • Application
    • Functional Food & Supplements
    • Infant Formulas
    • Laboratory Research

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Human Milk Oligosaccharides Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Human Milk Oligosaccharides Market, by Product
  7. Human Milk Oligosaccharides Market, by Type
  8. Human Milk Oligosaccharides Market, by Application
  9. Americas Human Milk Oligosaccharides Market
  10. Asia-Pacific Human Milk Oligosaccharides Market
  11. Europe, Middle East & Africa Human Milk Oligosaccharides Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 290]
  16. List of Companies Mentioned [Total: 23]
Human Milk Oligosaccharides: The Nutritional Powerhouse for Infants and Functional Food
December 5, 2023
Human Milk Oligosaccharides: The Nutritional Powerhouse for Infants and Functional Food
Human milk oligosaccharides (HMOs) are the third-largest solid component of human breast milk, which are far from digestible by the digestive enzymes. Instead, it passes through the digestive system unchanged and provides beneficial properties. HMOs have been shown to support the growth of essential bacteria in the gut and are essential for the immune system development. However, the nutrient is not limited to infants; its potential in the functional food market has grown tremendously. This blog explores the nutritional value of HMOs and their increasing application in infant formula and functional food.

Nutritional Value of HMOs:

HMOs are not like other carbohydrates, and the reason behind this is that they cannot be digested by the enzymes in the digestive system. Instead, they reach the large intestine intact and serve as "food" for vital microbes. These microbes function as a beneficial community in the gut, which helps boost immunity and prevent several diseases. A distinct feature of HMOs is their versatility in fermentation by gut microbes, allowing them to perform multiple functions and preventing pathogen attachment and colonization.

Increasing Application in Infant Formula:

HMOs in infant formula have recently gained much recognition due to their resemblance to breast milk and immune-boosting properties. HMOs have shown that they significantly improve gut health, establish healthy microbial environments, and reduce the risk of various infections. In response, many infant formula manufacturers are now adding HMOs in their formulations to create "human milk-like" products. The increased demand for HMOs in infant formula and the growing attention to providing optimal nutrition to babies is boosting the market size of the HMO industry.

Increasing Application in Functional Food:

Functional foods are becoming more prevalent in recent years as a way to achieve a healthier lifestyle. With HMOs' ability to enhance the immune system, control gut inflammation, and prevent microbial infections, they are becoming popular in functional food products. In some studies, HMOs have also been shown to have antiviral and antibacterial properties, making them a potential functional food for creating products to improve immunity against infections such as the flu. Moreover, HMOs bring prebiotic properties to the digestive system, encouraging good bacteria growth and activity leading to healthy gut microbiota.

HMOs are the nutritional powerhouse that is gaining attention for its potential benefits in infants and beyond. HMOs are unmatched in their ability to establish healthy gut microbial surroundings and improve the immune system. As more parents become aware of the benefits of HMOs, the demand for infant formula products with HMOs is increasing. Besides, the applications in functional food are becoming more promising and are expected to witness significant growth in the coming years. With its versatility in the food industry, HMOs' nutritional benefits are proving to be a significant opportunity for manufacturers and researchers to explore new uses and revolutionize the food industry.

Frequently Asked Questions
  1. How big is the Human Milk Oligosaccharides Market?
    Ans. The Global Human Milk Oligosaccharides Market size was estimated at USD 297.90 million in 2023 and expected to reach USD 323.44 million in 2024.
  2. What is the Human Milk Oligosaccharides Market growth?
    Ans. The Global Human Milk Oligosaccharides Market to grow USD 570.55 million by 2030, at a CAGR of 9.72%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.